adMare BioInnovations

adMare BioInnovations is a Canadian life sciences company creation engine, working with innovators and entrepreneurs to convert promising research into investable, globally competitive businesses. Its model combines early-stage capital with scientific and drug-development expertise, closing the gap between discovery and investment readiness. The organisation also operates turnkey laboratory and office facilities and runs talent and leadership development programmes for the sector.

Scale is substantial by Canadian standards. adMare reports helping build 54 companies and supporting more than 1,000 Canadian jobs. Companies it has backed have raised $2.5 billion in capital and reached an aggregate valuation of $5.8 billion. It holds more than 200,000 square feet of life sciences infrastructure and maintains offices in Vancouver, Toronto and Montreal.

The mandate spans life sciences, biotechnology and pharmaceuticals, with an underlying emphasis on de-risking innovation to improve patient outcomes and on the growth of a domestic Canadian industry. Beyond capital provision, the platform is explicitly partnership-oriented with entrepreneurs, and its investment activity is paired with hands-on scientific support and leadership development rather than financial backing alone.